CHAPTER 1 INTRODUCTION
1.1 Key benefits
1.2 Key market segments
1.3 Research methodology
1.3.1 Primary research
1.3.2 Secondary research
1.3.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market beyond: what to expect by 2025
2.1.1 Moderate growth scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Disposable versus reusable surgical instruments
3.3 Advanced surgical technologies
3.3.1 Emergence of robotic surgical equipments
3.3.1.1 Da Vinci Surgical System
3.3.2 Computer assisted surgical equipments
3.4 Key Findings
3.4.1 Top factors impacting surgical equipment market
3.4.2 Top investment pockets of surgical equipment market
3.4.3 Top winning strategies in surgical equipment market
3.5 Porter's five force analysis
3.5.1 Bargaining power of buyers
3.5.2 Bargaining power of suppliers
3.5.3 Threat of new entrants
3.5.4 Threat of substitute products
3.5.5 Intensity of competitive rivalry
3.6 Government Regulations
3.6.1 Medical devices regulations in the U.S.
3.6.2 Medical devices regulations in Europe and UK
3.6.3 Medical devices regulations in Asia-Pacific
3.7 Value chain analysis
3.7.1 Primary activities
3.7.2 Support activities
3.8 Case Studies
3.8.1 Multiple sterilization resistant surgical microtweezer: A case study of ERBE Elektromedizin GmbH
3.8.2 Stryker case & tray delivery system
3.8.3 Alcon Inc.: quanser brings new level of accuracy to laser eye surgery: mechatronics expertise used to solve integral challenge
3.9 Patent analysis
3.9.1 Patent analysis by region (2010-2014)
3.10 Surgical equipment market share analysis
3.11 Market dynamics
3.11.1 Drivers
3.11.1.1 Large pool of ageing population
3.11.1.2 Rise in number of surgeries
3.11.1.3 Growing demand for minimally invasive surgeries
3.11.1.4 Technological advances
3.11.2 Restraints
3.11.2.1 High price competition
3.11.2.2 Inadequate quality assurance and lack of proper sterilization of the equipments
3.11.2.3 Unfavorable taxation policy
3.11.3 Opportunities
3.11.3.1 Emerging economies
3.11.3.2 Advances in technology
CHAPTER 4 GLOBAL SURGICAL EQUIPMENT MARKET BY TYPE
4.1 Surgical sutures and staples
4.1.1 Key market trends
4.1.2 Competitive scenario
4.1.3 Key growth factors and opportunities
4.1.4 Market size & forecast
4.2 Handheld surgical devices
4.2.1 Scalpels
4.2.1.1 Key market trends
4.2.1.2 Competitive scenario
4.2.1.3 Key growth factors and opportunities
4.2.1.4 Market size &forecast
4.2.2 Forceps
4.2.2.1 Key market trends
4.2.2.2 Competitive scenario
4.2.2.3 Key growth factors and opportunities
4.2.2.4 Market size & forecast
4.2.3 Retractors
4.2.3.1 Key market trends
4.2.3.2 Competitive scenario
4.2.3.3 Key growth factors and opportunities
4.2.3.4 Market size & forecast
4.2.4 Scissors
4.2.4.1 Key market trends
4.2.4.2 Competitive scenario
4.2.4.3 Key growth factors and opportunities
4.2.4.4 Market size & forecast
4.3 Electrosurgical devices
4.3.1 Key market trends
4.3.2 Competitive scenario
4.3.3 Key growth factors and opportunities
4.3.4 Market size & forecast
4.4 Others
4.4.1 Power systems
4.4.2 Retraction systems
4.4.3 Market size & forecast
CHAPTER 5 GLOBAL SURGICAL EQUIPMENT MARKET BY APPLICATION
5.1 Neurosurgery
5.2 Plastic and reconstructive surgeries
5.3 Wound closure
5.4 Urology
5.5 Obstetrics and gynecology
5.6 Thoracic surgery
5.7 Microvascular
5.8 Cardiovascular
5.9 Orthopedic surgery
5.10 Laparoscopy
5.11 Others
CHAPTER 6 GLOBAL SURGICAL EQUIPMENT MARKET BY GEOGRAPHY
6.1 North America
6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Competitive scenario
6.1.4 Market size & forecast
6.1.5 United States
6.1.5.1 Market trends
6.1.5.2 Market size and forecast
6.1.6 Canada
6.1.6.1 Market trends
6.1.6.2 Market size and forecast
6.1.7 Mexico
6.1.7.1 Market trends
6.1.7.2 Market size and forecast
6.2 Europe
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Competitive scenario
6.2.4 Market size & forecast
6.2.5 Germany
6.2.4.1 Market trends
6.2.4.2 Market size and forecast
6.2.5 France
6.2.5.1 Market trends
6.2.5.2 Market size and forecast
6.2.6 United Kingdom (UK)
6.2.6.1 Market trends
6.2.6.2 Market size and forecast
6.2.7 Others
6.3 Asia Pacific
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Competitive scenario
6.3.4 Market size & forecast
6.3.5 India
6.3.5.1 Market trends
6.3.5.2 Market size and forecast
6.3.6 China
6.3.6.1 Market trends
6.3.6.2 Market size and forecast
6.3.7 Japan
6.3.7.1 Market trends
6.3.7.2 Market size and forecast
6.3.8 Australia
6.3.8.1 Market tends
6.3.8.2 Market size and forecast
6.3.9 Others
6.4 LAMEA
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Competitive scenario
6.4.4 Market size & forecast
6.4.5 Latin America
6.4.5.1 Market trends
6.4.5.2 Market size and forecast
6.4.6 Middle East
6.4.6.1 Market trends
6.4.6.2 Market size and forecast
6.4.7 Africa
6.4.7.1 Market trends
6.4.7.2 Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Medtronic, Inc.
7.1.1 Company overview
7.1.2 Business performance
7.1.3 Strategic moves and developments
7.1.3.1 Principal strategy: approvals
7.1.3.2 Secondary strategy : product launch and acquisition
7.1.4 SWOT analysis
7.2 Stryker Corporation
7.2.1 Company overview
7.2.2 Business performance
7.2.3 Strategic moves and developments
7.2.3.1 Principal strategy: scquisition
7.2.3.2 Secondary strategy: approval
7.2.4 SWOT analysis
7.3 Conmed Corporation
7.3.1 Company overview
7.3.2 Business performance
7.3.3 Strategy move and development
7.3.3.1 Principal strategy: product launch
7.3.3.2 Secondary strategy: acquisition
7.3.4 SWOT analysis
7.4 Carefusion Corporation
7.4.1 Company overview
7.4.2 Business performance
7.4.3 Strategic moves and developments
7.4.3.1 Principal strategy: approvals
7.4.3.2 Secondary strategy : acquisition
7.4.4 SWOT analysis
7.5 Alcon Laboratories Inc.
7.5.1 Company overview
7.5.2 Business performance
7.5.3 Strategic moves and developments
7.5.3.1 Principal strategy: product launch
7.5.3.2 Secondary strategy : acquisition and approval
7.5.4 SWOT analysis
7.6 Smith & Nephew Plc
7.6.1 Company overview
7.6.2 Business performance
7.6.3 Strategic moves and developments
7.6.3.1 Principal strategy: product launch
7.6.3.2 Secondary strategy : acquisition
7.6.4 SWOT analysis
7.7 Ethicon Inc.
7.7.1 Company overview
7.7.2 Business performance
7.7.3 Strategic moves and developments
7.7.3.1 Principal strategy: approval
7.7.3.2 Secondary strategy :product launch and collaboration
7.7.4 SWOT analysis
7.8 B. Braun Melsungen AG (Aesculap Inc.)
7.8.1 Company overview
7.8.2 Business performance
7.8.3 Strategic moves and developments
7.8.3.1 Principal strategy: product launch
7.8.3.2 Secondary strategy : acquisition
7.8.4 SWOT analysis
7.9 Zimmer Holdings Inc.
7.9.1 Company overview
7.9.2 Business performance
7.9.3 Strategic moves and developments
7.9.3.1 Principal strategy: product launch
7.9.3.2 Secondary strategy : approval
7.9.4 SWOT analysis
7.10 KLS Martin Group
7.10.1 Company overview
7.10.2 Strategic moves and developments
7.10.2.1 Principal strategy: product launch
7.10.3 SWOT analysis